Webinar

The impact of Omega-3 on healthy ageing: how increased intake can improve heart health factors

Format: External webinar | Document type: Webinar

The impact of Omega-3 on healthy ageing: how increased intake can improve heart health factors

Related categories: Omega-3s & Nutritional oils

Cardiovascular disease (CVD) continues to be the leading cause of mortality globally. In the Asia Pacific region, rapidly aging populations drives the need for proven solutions that support consumers in living a longer, more active and fulfilling life.

Nutrition is an important lever in keeping the cardiovascular system functioning optimally. Arterial stiffness is an independent predictor of cardiovascular disease events and may be differentially affected by dietary fatty acid (FA) intake. A higher intake and higher concentrations of circulating omega-3 fatty acids have a positive influence on lowering arterial stiffness, resulting in a better CVD risk profile.

A recognised measure of the concentration of circulating omega-3 fatty acids is the omega-3 index, which is now easily measured via Dried Blood Spot (DBS) technology. The omega-3 index is defined as the total concentration of EPA and DHA in red blood cells, expressed as a percentage of total fatty acid content. A higher omega-3 index has been associated with reduced risk of cardiovascular events.

BASF shares the scientific evidence behind the efficacy of PronovPure® high concentrate omega-3 products and AccelonTM​ omega-3 absorption technology on increasing the omega-3 index for desired cardiovascular health outcomes.

Watch Now

Speakers

Shawn Shawn Lee Senior Regional Marketing Manager
BASF Human Nutrition Asia Pacific

KaiLin Ek Kai Lin Senior Regional Manager for Scientific Marketing
BASF Human Nutrition Asia Pacific

Vic Leodevico L. Ilag Chief Scientific Officer
Xerion Limited

Latest content from BASF

BASF offers most efficient boost yet for Omega-3 Index

Content provided by BASF

BASF offers most efficient boost yet for Omega-3 Index

The Omega-3 Index has low mainstream awareness despite significant importance for consumer health. It could also be missing link in Omega-3 clinical trials. BASF study reinforces potential: Accelon™ 5x more likely to move consumers to Low Risk Zone.

Supplier info centre